ArticleThe Journal of clinical investigation2025

Early CD4+ T cell proliferation and chronic T cell engagement impact myeloma outcomes following T cell engager therapy.

Alyssa M Duffy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.